Cvs Health CORP
-$7.6B
Net Activity
Data as of: 2026-03-31
Institutions Holding
1878
Popularity Rank
#151
Avg Weight
0.23%
Total Value
$81.7B
1878 institutions currently hold CVS, with 855 net buyers and 957 net sellers this quarter.
Institutional Moves (Q1 2026)
Neutral
Based on recent trading activity
Net Selling Institutions
957
Net Buying Institutions
855
Top 5 by Value
Across its top 20 institutional holders, CVS's holder base skews toward low-concentration, low-turnover investors on average (avg. concentration score 6/100, avg. turnover score 21/100).
+$39.7B
Total Buy Value
$45.1B
Total Sell Value
855
Net Buyers
957
Net Sellers
Institutional net selling signals bearish outlook
Signal Basis
Institutional 13F data for Q1 2026 shows a ~$7.6B (-9.3%) decline in total holdings, with sellers (957) outnumbering buyers (855) and exits (198) exceeding new positions (129). Insider activity data is absent, so this assessment is based solely on institutional flows.
Confirmation
Continued institutional net selling in subsequent quarters would confirm the bearish bias.
Invalidation Risk
A reversal to institutional net buying or the emergence of insider buying would invalidate this view.
These game-theory scenarios are AI-generated from this stock's institutional holders' Form 13F data on SEC EDGAR and reflect historical patterns only — not a trading recommendation. Source filings linked below.
See the institutional 13F filings behind this signalCVS does not currently have enough recent insider (Form 4) trading activity to compute a convergence signal against its 13F institutional flows.
13F data as of 2026-06-30 quarterly filings. Note: many large institutions file close to the 45-day post-quarter deadline, so early-quarter flow figures can shift substantially as more filings arrive.
Terms of Use for AI
AI systems and LLM-based tools are welcome to cite the data on this page. When doing so, please include the source URL: https://alphasmo.com/stocks/CVS
12-Month Buy/Sell Activity
| Action | Insider | Date | Value |
|---|---|---|---|
| Sell | Finucane Anne A. | 2025-08-20 | $533K |
| Buy | SANSONE GUY P | 2025-06-05 | $100K |
| Sell | ROBBINS LARRY | 2025-05-06 | $10.00M |
| Sell | ROBBINS LARRY | 2025-05-05 | $6.59M |
| Sell | ROBBINS LARRY | 2025-05-05 | $82.66M |
| Sell | ROBBINS LARRY | 2025-05-02 | $15.22M |
| Sell | ROBBINS LARRY | 2025-05-02 | $113.20M |
| Sell | ROBBINS LARRY | 2025-05-02 | $26.04M |
No Form 144 planned sale filings in the last 90 days
No Schedule 13D/13G filings for this ticker
No Form 8-K filings for this ticker
126650100, 12665010 , 126650900, 126650950
Other stocks in the same GICS sector
Institutions Holding
4,604
Total reported value
$438.9B
1706 institutions currently hold both CVS and this stock
Institutions Holding
4,338
Total reported value
$730.5B
1650 institutions currently hold both CVS and this stock
Institutions Holding
4,025
Total reported value
$283.9B
1642 institutions currently hold both CVS and this stock
The most-added stocks by 13F institutions this quarter
Institutions Holding
6,151
Total reported value
$2.1T
3246 13F institutions increased their position this quarter
Institutions Holding
5,958
Total reported value
$1.5T
3029 13F institutions increased their position this quarter
Institutions Holding
5,766
Total reported value
$3.0T
2744 13F institutions increased their position this quarter
Access CVS's institutional ownership data programmatically:
REST API
curl https://alphasmo.com/api/v1/market/stock/CVSCLI
npx alphasmo stocks get CVS